Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Key Points: TLR4 and 7 agonists improve titers when coformulated with alum but not an emulsion formulation, but do not impact the titer half-lives. Alum/TLR7 and pIC:LC are potent adjuvant formulations that improve the magnitude and quality of humoral and cellular responses to HIV Env.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Kwissa, M., Nakaya, H. I., Oluoch, H., & Pulendran, B. (2012) · Blood · doi:10.1182/blood-2011-10-388579 · Cited by 132 · cited 3×
“Thus, nonhuman primates (NHPs) provide a unique opportunity to assess multiple adjuvants in parallel for translation to humans.(23,28,57) Moreover, an in-depth analysis of humoral immunity has not been applied to a comparative adjuvant HIV study in NHPs nor integrated with innate transcriptional profiling.”
Background
Cited by
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Self-citationCorrelates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
HogenEsch, H., O’Hagan, D. T., & Fox, C. B. (2018) · npj Vaccines · doi:10.1038/s41541-018-0089-x · Cited by 391
Self-citationMalaria Vaccines: Recent Advances and New Horizons
Draper, S. J., Sack, B. K., King, C. R., Nielsen, C. M., Rayner, J. C., Higgins, M. K., Long, C. A., & Seder, R. A. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.008 · Cited by 331
Self-citationAdjuvanting a subunit COVID-19 vaccine to induce protective immunity
Arunachalam, P. S., Walls, A. C., Golden, N., Atyeo, C., Fischinger, S., Li, C., Aye, P., Navarro, M. J., Lai, L., Edara, V. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03530-2 · Cited by 326
Self-citation
Metadata
- Authors
- Francica, J. R., Zak, D. E., Linde, C., Siena, E., Johnson, C., Juraska, M., Yates, N. L., Gunn, B., De Gregorio, E., Flynn, B. J., Valiante, N. M., Malyala, P., Barnett, S. W., Sarkar, P., Singh, M., Jain, S., Ackerman, M., Alam, M., Ferrari, G., Salazar, A., Tomaras, G. D., O’Hagan, D. T., Aderem, A., Alter, G., & Seder, R. A.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2017-11-17
- Volume
- 1
- Issue
- 25
- Pages
- 2329-2342
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- OpenAlex
- W2768263828
- Cited by
- 93
- References
- 3
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. https://app.cochat.ai/papers/10.1182/bloodadvances.2017011411
- The paper
- Francica, J. R., Zak, D. E., Linde, C., Siena, E., Johnson, C., Juraska, M., Yates, N. L., Gunn, B., De Gregorio, E., Flynn, B. J., Valiante, N. M., Malyala, P., Barnett, S. W., Sarkar, P., Singh, M., Jain, S., Ackerman, M., Alam, M., Ferrari, G., . . . Seder, R. A. (2017). Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Advances. https://doi.org/10.1182/bloodadvances.2017011411
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.